Study of the Reduction of the Prescriptions of Benzodiazepines and Related

NCT06107283 | Unknown

• 1 other identifier: 8787
• Study Type: observational
• Target: 150
• Locations: 1 country
• Sites: 1

Brief Summary

The significant consumption of Benzodiazepines and related drugs in the elderly outside of good practice recommendations is a major issue in the care of the elderly. Adverse effects have been the subject of numerous studies, leading to falls, addictions and even deaths. The general practitioner is often faced with long-term medication intake which is not consistent with a good benefit/risk balance, but stopping or reducing the dosage remains a problem in current practice. The Aftercare and Geriatric Rehabilitation services due to their operation (several weeks of hospitalization) seek to adapt the patient's therapies in order to obtain the most convincing benefit/risk balance possible. A reduction or withdrawal of treatments with Benzodiazepines or related drugs are therefore frequently initiated.

Conditions

Depression in Old Age

Keywords

Depression in Old Age; Benzodiazepines drugs; Geriatrics

Outcome Measures

Primary Outcomes (1)

• The number of patients who had an increase in Benzodiazepines in the 12 weeks following discharge from hospitalization.

  12 weeks following discharge from hospitalization.

Eligibility Criteria

• Age: 75 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Major subject (≥ 75 years old) discharged from a geriatric Follow-up Care and Rehabilitation service for whom a reduction in the dosage of Benzodiazepines and related drugs was carried out during hospitalization and who returned home (individual or EHPAD) after hospitalization.

You may qualify if:

• Major subject (≥ 75 years old)
• Subject discharged from a geriatric Follow-up Care and Rehabilitation service for whom a reduction in the dosage of Benzodiazepines and related drugs was carried out during hospitalization and who returned home (individual or EHPAD) after hospitalization.
• Subject not opposing, after information, the reuse of their data for the purposes of this research.

You may not qualify if:

• Subject having expressed opposition to participating in the study.
• Subject having treatment with Benzodiazepine to prevent recurrence of epileptic seizures.

Sponsors & Collaborators

• University Hospital, Strasbourg, France: lead

Study Sites (1)

Gériatrie - Service de Soins de Soins Médicaux et de Réadaptation - CHU de Strasbourg - France

Strasbourg, 67091, France

RECRUITING

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: October 24, 2023
• First Posted: October 30, 2023
• Study Start: March 1, 2023
• Primary Completion: August 1, 2024
• Study Completion: August 17, 2024
• Last Updated: October 30, 2023

Record last verified: 2023-10

Locations

FR (1)